• Return to Headlines

Possible Trend Reversal, Nektar Therapeutics Down on Heavy Volume (NKTR)

By Shiri Gupta

Nektar Therapeutics's stock is up 26.1% to $19.55 on heavy trading volume. Approximately 2.0 million shares have changed hands today vs. average 30-day volume of 1.1 million shares. Unusually high volume can signify a potential turning point or validate a breakout.

SmarTrend recommended that subscribers consider buying shares of Nektar Therapeutics on March 2nd, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $14.06. Since that recommendation, shares of Nektar Therapeutics have risen 10.3%. We continue to monitor NKTR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

In the past 52 weeks, shares of Nektar Therapeutics have traded between a low of $9.16 and a high of $19.98 and are now at $19.55, which is 113% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.1% while the 200-day MA has risen 0.3%.

Keywords: unusual volume nektar therapeutics

Ticker(s): NKTR